Vaccines for the prevention of neglected diseases--dengue fever.
Dengue and dengue hemorrhagic fever have spread to all tropical areas of the developing world, but still remain largely neglected diseases. Several promising vaccine candidates in the form of live attenuated and chimeric vaccines have been developed and are currently in human clinical trials. However, significant practical, logistic, and scientific challenges remain before these vaccines can widely and safely be applied to vulnerable populations. Vector control, community education and public health measures must be pursued in parallel with vaccine development.
Pang
Tikki
T
Research Policy & Cooperation, World Health Organization, Avenue Appia, 1211 Geneva 27, Switzerland. pangt@who.int
D003715:Dengue / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods* / Q000639:trends; D019595:Severe Dengue / Q000517:prevention & control; D014612:Vaccines / Q000145:classification* / Q000627:therapeutic use*; D014613:Vaccines, Attenuated / Q000627:therapeutic use
D014612:Vaccines; D014613:Vaccines, Attenuated